Do you want to read an article? Please log in or register.
Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group
Multiple Myeloma (MM)
Related content
Multiple Myeloma (MM)
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Lancet Oncol
Moreau P, Kumar SK, San Miguel J, Davies F, Zamagni E, Bahlis N, Ludwig H, Mikhael J, Terpos E, Schjesvold F, Martin T, Yong K, Durie BGM, Facon T, Jurczyszyn A, Sidana S, Raje N, van de Donk N, Lonial S, Cavo M, Kristinsson SY, Lentzsch S, Hajek R, Anderson KC, João C, Einsele H, Sonneveld P, Engelhardt M, Fonseca R, Vangsted A, Weisel K, Baz R, Hungria V, Berdeja JG, Leal da Costa F, Maiolino A, Waage A, Vesole DH, Ocio EM, Quach H, Driessen C, Bladé J, Leleu X, Riva E, Bergsagel PL, Hou J, Chng WJ, Mellqvist UH, Dytfeld D, Harousseau JL, Goldschmidt H, Laubach J, Munshi NC, Gay F, Beksac M, Costa LJ, Kaiser M, Hari P, Boccadoro M, Usmani SZ, Zweegman S, Holstein S, Sezer O, Harrison S, Nahi H, Cook G, Mateos MV, Rajkumar SV, Dimopoulos MA, Richardson PG
doi: 10.1016/S1470-2045(20)30756-7
Multiple Myeloma (MM)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Lancet Oncol.
Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Bladé J, Mateos MV, Dimopoulos M, Kastritis E, Boccadoro M, Orlowski R, Goldschmidt H, Spencer A, Hou J, Chng WJ, Usmani SZ, Zamagni E, Shimizu K, Jagannath S, Johnsen HE, Terpos E, Reiman A, Kyle RA, Sonneveld P, Richardson PG, McCarthy P, Ludwig H, Chen W, Cavo M, Harousseau JL, Lentzsch S, Hillengass J, Palumbo A, Orfao A, Rajkumar SV, San Miguel J, Avet-Loiseau H
doi: 10.1016/
Radio-OncologyMultiple Myeloma (MM)
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study
Lancet Oncol.
Raje N, Terpos E, Willenbacher W, Shimizu K, García-Sanz R, Durie B, Legieć W, Krejčí M, Laribi K, Zhu L, Cheng P, Warner D, Roodman GD
Multiple Myeloma (MM)
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report
Blood Cancer J
Murray DL, Puig N, Kristinsson S, Usmani SZ, Dispenzieri A, Bianchi G, Kumar S, Chng WJ, Hajek R, Paiva B, Waage A, Rajkumar SV, Durie B
doi: 10.1038/s41408-021-00408-4
Multiple Myeloma (MM)
The multiple myeloma treatment landscape: international guideline recommendations and clinical practice in Europe
Expert Rev Hematol.
Cavo M, Terpos E, Bargay J, Einsele H, Cavet J, Greil R, de Wit E
doi: 10.1080/
Multiple Myeloma (MM)
Advanced Imaging of Multiple Myeloma Bone Disease
Front Endocrinol (Lausanne).
Hansford BG, Silbermann R
doi: 10.3389/fendo.2018.00436.
COMMENTED
Multiple Myeloma (MM)
Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial
★ 1
Recommended and commented by
Prof. Dr Christoph Renner, Faculty Member
doi: 10.1016/S2352-3026(20)30070-3.
Multiple Myeloma (MM)
Transplant eligibility in elderly Multiple Myeloma patients: prospective external validation of the International Myeloma Working Group (IMWG) frailty score and comparison with clinical judgment and other comorbidity scores in unselected patients aged 65-75 years
Am J Hematol.
Belotti A, Ribolla R, Cancelli V, Crippa C, Bianchetti N, Ferrari S, Bottelli C, Cattaneo C, Tucci A, Barrigon CF, Rossi G
doi: 10.1002/ajh.25797.
Multiple Myeloma (MM)
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when
doi: 10.3324/haematol.